- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 1089-1103 of
1,230 results
1103 Exhibit: Second Declaration of James L Mullins, PhD
Document
IPR2021-00816, No. 1103 Exhibit - Second Declaration of James L Mullins, PhD (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1171 Exhibit: Declaration of Lisa Cameron ��� List of Materials Considered
Document
IPR2021-00816, No. 1171 Exhibit - Declaration of Lisa Cameron ��� List of Materials Considered (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1202 Exhibit: Highlights of Prescribing Information, Lucentis, FDA, revised August ...
Document
IPR2021-00816, No. 1202 Exhibit - Highlights of Prescribing Information, Lucentis, FDA, revised August 2012 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1111 Exhibit: Nishimoto, et al, Determination of Conditions for the Production Scale...
Document
IPR2021-00816, No. 1111 Exhibit - Nishimoto, et al, Determination of Conditions for the Production Scale Sterilization of Prefilled Syringes, 57 PDA J Pharm Sci Tech, 378 386 2003 (P.T.A.B. Ap...
|
|
Cite Document
1200 Exhibit: Highlights of Prescribing Information, Lucentis, FDA, revised October...
Document
IPR2021-00816, No. 1200 Exhibit - Highlights of Prescribing Information, Lucentis, FDA, revised October 2016 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1196 Exhibit: Highlights of Prescribing Information, Vabysmo, revised January 202...
Document
IPR2021-00816, No. 1196 Exhibit - Highlights of Prescribing Information, Vabysmo, revised January 2022, (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1190 Exhibit: Angus Liu, Novartis calls off 3 Beovu trials testing more frequent dosi...
Document
IPR2021-00816, No. 1190 Exhibit - Angus Liu, Novartis calls off 3 Beovu trials testing more frequent dosing on concerns of vision threatening side effect, FiercePharma, June 1, 2021 (P.T.A.B. A...
|
|
Cite Document
1243 Exhibit: Kevin L Varghese, No Need to Neglect Nexus Prosecution Lessons fr...
Document
IPR2021-00816, No. 1243 Exhibit - Kevin L Varghese, No Need to Neglect Nexus Prosecution Lessons from FOX Factory v SRAM, Intellectual Property Tech Law J, 326 16 June 2020 (P.T.A.B. A...
|
|
Cite Document
1227 Exhibit: REG NDNY 00000004 Gilead Sciences Inc Form 10 K 36
Document
IPR2021-00816, No. 1227-3 Exhibit - REG NDNY 00000004 Gilead Sciences Inc Form 10 K 36 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1245 Exhibit: Excerpt of Opening Report of Szilard Kiss, MD, ITC Inv No 337 TA 120...
Document
IPR2021-00816, No. 1245-2 Exhibit - Excerpt of Opening Report of Szilard Kiss, MD, ITC Inv No 337 TA 1207 Jan 22, 2021 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1236 Exhibit: ���Highlights of Prescribing Information,��� Eylea, FDA, revised Septem...
Document
IPR2021-00816, No. 1236 Exhibit - ���Highlights of Prescribing Information,��� Eylea, FDA, revised September 2012 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1170 Exhibit: Curriculum Vitae of Lisa Cameron
Document
IPR2021-00816, No. 1170 Exhibit - Curriculum Vitae of Lisa Cameron (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1235 Exhibit: ���Highlights of Prescribing Information,��� Eylea, FDA, revised Augus...
Document
IPR2021-00816, No. 1235 Exhibit - ���Highlights of Prescribing Information,��� Eylea, FDA, revised August 2019 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1246 Exhibit: GlobalData Healthcare, The dominance of Eylea is expected to persis...
Document
IPR2021-00816, No. 1246 Exhibit - GlobalData Healthcare, The dominance of Eylea is expected to persist in the foreseeable future, Pharma Tech, July 1, 2020 updated Dec 1, 2021 (P.T.A.B. Ap...
|
|
Cite Document
1172 Exhibit: Deposition of James E Malackowski, IPR2021 00816 3292022
Document
IPR2021-00816, No. 1172-2 Exhibit - Deposition of James E Malackowski, IPR2021 00816 3292022 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
